Sponsor:
Fred Hutchinson Cancer Center
Code:
NCT04515810
Conditions
Locally Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Recurrent Hematologic Malignancy
Refractory Hematologic Malignancy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Internet-Based Intervention
Best Practice
Telephone-Based Intervention
Questionnaire Administration
Post-intervention qualitative feedback interview
Brief summary:
Conditions
Locally Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Recurrent Hematologic Malignancy
Refractory Hematologic Malignancy
Study ID
NCT04515810
Start date
Feb 18, 2025
Status verified date
Aug, 2026
Completion date
Aug 31, 2027
Anticipated
Primary completion date
May 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
400 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Health Services Research
Arms
experimental: Arm I (PACT)
active comparator: Arm II (standard care)
Interventions
Internet-Based Intervention
Best Practice
Telephone-Based Intervention
Questionnaire Administration
Post-intervention qualitative feedback interview
Primary outcome measure
Central contacts
Locations
Fred Hutch/University of Washington Cancer Consortium
Recruiting
Seattle, Washington, United States, 98109
Contacts
Principal Investigator:
Megan J Shen, PhD
Sponsor
Fred Hutchinson Cancer Center
Last update posted
Aug 17, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Fred Hutchinson Cancer Center on 2026-08-17.